Morixe Hermanos S.A.C.I. (BCBA:MORI)

Orchard Therapeutics Balance Sheet

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	May 31, 2023	May 31, 2022	May 31, 2021
Cash & Equivalents	8,104	8,668	4,328	635.9	340.63	30.78
Short-Term Investments	3,042	5,496	2,342	752.29	532.74	260.63
Cash & Short-Term Investments	11,145	14,164	6,670	1,388	873.37	291.41
Cash Growth	702.86%	112.35%	380.47%	58.95%	199.70%	270.90%
Accounts Receivable	12,673	7,819	15,074	5,302	3,442	1,121
Other Receivables	5,086	3,891	2,923	2,478	1,506	474.97
Receivables	17,759	11,710	17,997	7,780	4,948	1,595
Inventory	23,295	19,657	24,618	13,479	6,134	1,937
Other Current Assets	4,497	4,267	2,413	2,315	1,392	465.29
Total Current Assets	56,696	49,797	51,698	24,962	13,348	4,289
Property, Plant & Equipment	42,173	38,824	42,636	16,975	6,929	1,661
Goodwill	2,979	1,077	1,138	19.93	14.83	5.97
Other Intangible Assets	1,048	982.26	616.95	279.47	98.16	25.02
Other Long-Term Assets	275.46	307.8	1,539	1,448	1,445	286.79
Total Assets	103,170	90,988	97,628	43,684	21,835	6,268
Accounts Payable	20,899	16,695	21,506	6,590	5,338	1,544
Accrued Expenses	1,348	1,236	1,401	364.82	155.01	34.32
Current Portion of Long-Term Debt	20,114	15,754	18,446	11,140	5,000	823.7
Current Portion of Leases	-	-	-	10.32	6.73	31.9
Current Income Taxes Payable	1,088	754.61	-	1.49	1.34	0.6
Current Unearned Revenue	4,179	6,297	-	-	-	-
Other Current Liabilities	1,903	564.74	417.75	215.25	61.34	21.41
Total Current Liabilities	49,531	41,302	41,770	18,322	10,562	2,456
Long-Term Debt	1,448	1,880	5,179	4,603	2,649	987.78
Long-Term Leases	-	-	-	-	-	2.15
Long-Term Deferred Tax Liabilities	6,393	6,117	5,699	3,420	1,062	355.7
Other Long-Term Liabilities	1,948	1,758	4,074	169.92	150.2	75.41
Total Liabilities	59,320	51,057	56,722	26,515	14,423	3,877
Common Stock	281.9	281.9	281.9	281.9	281.9	281.9
Additional Paid-In Capital	17,554	16,169	16,169	7,425	3,391	985.02
Retained Earnings	7,763	6,582	3,010	1,074	146.09	261.76
Comprehensive Income & Other	18,246	16,898	21,444	8,388	3,593	862.65
Shareholders' Equity	43,850	39,930	40,905	17,169	7,412	2,391
Total Liabilities & Equity	103,170	90,988	97,628	43,684	21,835	6,268
Total Debt	21,562	17,635	23,625	15,753	7,655	1,846
Net Cash (Debt)	-10,416	-3,471	-16,955	-14,365	-6,782	-1,554
Net Cash Per Share	-36.55	-12.31	-60.13	-50.97	-24.06	-6.04
Filing Date Shares Outstanding	281.9	281.9	281.96	281.9	281.9	281.9
Total Common Shares Outstanding	281.9	281.9	281.96	281.9	281.9	281.9
Working Capital	7,165	8,496	9,927	6,640	2,786	1,834
Book Value Per Share	155.53	141.65	145.08	60.90	26.29	8.48
Tangible Book Value	39,819	37,872	39,151	16,870	7,299	2,360
Tangible Book Value Per Share	141.25	134.34	138.85	59.84	25.89	8.37
Machinery	28,917	26,286	29,556	9,053	2,647	728.4
Construction In Progress	540.79	369.74	873.36	872.79	1,541	46.83
Leasehold Improvements	400.66	369.04	369.04	163.14	57.56	4.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.